A newly published research modeling shows that using a vaccine with comprehensive response to HIV/AIDS could successfully eliminate the epidemic around the world.
The study concentrated on low- or middle-income
countries that have the highest rates of HIV/AIDS patients. When the researchers added a vaccine to the model, infections of HIV and deaths related to AIDS declined significantly.
“These new analyses underscore the powerful potential of an AIDS vaccine to help save and improve the lives of millions in a cost-effective manner,” Mark Feinberg, president and CEO of the International AIDS Vaccine Initiative, said. “It is clear that we must continue to expedite development of an effective HIV vaccine alongside the critical efforts to accelerate and sustain broad and equitable access to effective antiretroviral therapy and new approaches for pre-exposure prophylaxis.”
The study, published in PLOS Pathogens, showed significant change was notable even if the researchers also increased other preventions and treatments
“Adding a vaccine to a comprehensive HIV/AIDS response will hasten the end of the global epidemic and ensure that it won’t rebound,” Mitchell Warren, AVAC’s executive director, said. “A safe, effective and affordable AIDS vaccine is an essential complement to the existing treatment and prevention options, and this study highlights why accelerated investments are needed for both implementation of what we have and the development of what we still need.”
